v3 Template
A

Aramis Biotechnologies

Biotechnology ~10 employees
Founded
--
Employees (Est.)
~10
1 leaders known
Total Funding
$40.0M
Funding Rounds
1
Last Funding
2024-12-05

About Aramis Biotechnologies

Aramis Biotechnologies is a Canadian biotechnology company founded in 2023, based in Quebec, with the majority of its capital held by employees. The company aims to protect health through innovative biotechnological solutions.

Products & Services

Plant-based Biofabrication Platform:A new generation platform using plant cells to address current public health needs and prepare for future pandemics.
Seasonal Flu Vaccine:A vaccine under development that will pave the way for broader applications of their platform for human health.

Specialties

Plant-based vaccine technology Biofabrication Public health solutions Pandemic preparedness

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Strategic Investment
T: -
FT: Strategic Investment 		A: 40000000
MR: -
FA: $40 million
FAN: 40000000 		D: 2024-12-05
FD: 2024-12-05 		1 investors
Strategic Investment Latest
2024-12-05
$40.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

F

Frédéric Ors

President and Chief Executive Officer

Recent News

Aramis Biotechnologies Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~10 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro